MiMedx Group скачать в хорошем качестве

MiMedx Group

Thomas Koob, Ph.D., Chief Scientific Officer Marietta, GA (NASDAQ: MDXG) MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. “Innovations in Regenerative Biomaterials” is the framework behind the Company’s mission to provide physicians with products and tissues to help the body heal itself. MiMedx’s biomaterial platform technologies include AmnioFix® and EpiFix®, tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the Company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. The Company processes the human amniotic membrane utilizing its proprietary PURION® process, to produce a safe and effective allograft. MiMedx is the leading supplier of amniotic tissue, having supplied hundreds of thousands of allografts to date for application in the wound care, surgical, sports medicine, ophthalmic and dental sectors of healthcare. www.mimedx.com